Condition: Severe Sickle Cell Disease · Bone Marrow Failure Syndromes · Metabolic Disorders · Sponsor: Washington University School of Medicine
This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years of age and could benefit from the procedure.
This description comes directly from the study's public registry record.
Shalini Shenoy, MD · 314-454-6018 · shalinishenoy@wustl.edu
Ian Snyder, BS, CCRP · 314-273-5953 · ian.s@wustl.edu
Always discuss trial participation with your own doctor first.
| Yale School of Medicine | New Haven, Connecticut, United States | Recruiting |
| Nemours Children's Health | Wilmington, Delaware, United States | Recruiting |
| Helen DeVos Children's Hospital | Grand Rapids, Michigan, United States | Recruiting |
| Washington University School of Medicine | St Louis, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03128996